Design of a slide show to explain the working principle of their latest antiviral, Islatravir (anti-HIV).
Despite the discoveries of the last few years, often combined in the form of triple therapy, new strains resistant to nucleoside inhibitors (NRTI) are appearing.
The aim of this work was to make the research and discoveries that led MSD to develop Islatravir accessible, this new molecule being the first Reverse Transcriptase Translocation Inhibitor. The work was carried out under the supervision of Dr Jean-Claude TARDY, Virologist at the Hospices Civils de Lyon.
